AI MARKET SCANNING

$ALT

Altimmune, Inc.

United StatesUNITED STATES
FREE PREVIEW
🌐 Website🏛️ NASDAQ📁 Healthcare🏭 Biotechnology
AVG HISTORICAL GAP1.83%
MAX GAP RECORD7.75%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $ALT

EXECUTIONS0
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
RADAR SCANNING: WAITING FOR NEXT CATALYST
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.2%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg,… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL

AI INSIGHTS & REPORTS FOR $ALT

AI REPORT
Sep 15

VRA Earnings Gap Anticipation: A Deep Dive into Market Sentiment

VRA Earnings Preview: What Investors Need to KnowAs the markets grapple with the latest developments in AI-driven sectors,…
VIEW REPORT_
AI REPORT
Sep 14

Lindex Group OYJ Forecast and Analysis: Navigating Market Volatility

Analysis The financial markets have recently experienced a period of heightened volatility, with sectors showing varied levels of…
VIEW REPORT_
AI REPORT
Sep 13

This Week in Quant: A Deeper Dive into Market Dynamics

Analysis Markets this week exhibited a mix of volatility and strategic positioning as participants adapted to shifting macroeconomic…
VIEW REPORT_